To validate the effects of SREBP1 knockdown on death receptor sensitization and determine the effects of its knockdown in other cell lines, HeLa cervical cancer and DU145 prostate cancer cells were stably infected with shRNA targeting SREBP1 or control sequences. The gene discussed is SREBF1; the disease is prostate carcinoma.